Evidence map›Paper›PMID 19255043›Full record

ArticleThe American journal of psychiatry2009

Identification of a schizophrenia-associated functional noncoding variant in NOS1AP.

Naomi S Wratten, Holly Memoli, Yungui Huang, Anna M Dulencin, Paul G Matteson, Michelle A Cornacchia, Marco A Azaro, Jaime Messenger, Jared E Hayter, Anne S Bassett and 4 more

Erratum issuedAbstract read
In one paragraph

Article in The American journal of psychiatry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Association ofHealth science reports · 2024
    Article
  4. Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  5. Article
  6. Article
  7. Genetic Factors of Nitric Oxide's System in Psychoneurologic Disorders.International journal of molecular sciences · 2020
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Naomi S WrattenRutgers University Department of Genetics, 145 Bevier Road, Piscataway, NJ 08854, USA.
Holly Memoli
Yungui Huang
Anna M Dulencin
Paul G Matteson
Michelle A Cornacchia
Marco A Azaro
Jaime Messenger
Jared E Hayter
Anne S Bassett
Steven Buyske
James H Millonig
Veronica J Vieland
Linda M Brzustowicz
Rutgers, The State University of New Jersey · US

Funding

Molecular Genetics of Schizophrenia SusceptibilityR01MH062440 · NIMH · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BRZUSTOWICZ, LINDA M · 2001 to 2008
$3.4M
Identification and Functional Assessment of Autism Susceptibility GenesR01MH076624 · NIMH · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MILLONIG, JAMES H. · 2005 to 2009
$2.1M
Identification/Assessment of Autism Susceptibility GenesR01MH076433 · NIMH · UNIVERSITY OF IOWA · PI VIELAND, VERONICA J. · 2005 to 2009
$1.4M
Phenotype Based Approaches in Statistical GeneticsK25AA015346 · NIAAA · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BUYSKE, STEVEN G · 2005 to 2009
$527k
CIHR 12155NIAAA NIH HHS K25 AA015346NIMH NIH HHS R01 MH062440NIMH NIH HHS R01 MH076433NIMH NIH HHS R01 MH076624NIMH NIH HHS R01 MH62440NIMH NIH HHS R01 MH76433
6 · The paper itself

Abstract

objectiveThe authors previously demonstrated significant association between markers within NOS1AP and schizophrenia in a set of Canadian families of European descent, as well as significantly increased expression in schizophrenia of NOS1AP in unrelated postmortem samples from the dorsolateral prefrontal cortex. In this study the authors sought to apply novel statistical methods and conduct additional biological experiments to isolate at least one risk allele within NOS1AP.

methodUsing the posterior probability of linkage disequilibrium (PPLD) to measure the probability that a single nucleotide polymorphism (SNP) is in linkage disequilibrium with schizophrenia, the authors evaluated 60 SNPs from NOS1AP in 24 Canadian families demonstrating linkage and association to this region. SNPs exhibiting strong evidence of linkage disequilibrium were tested for regulatory function by luciferase reporter assay. Two human neural cell lines (SK-N-MC and PFSK-1) were transfected with a vector containing each allelic variant of the SNP, the NOS1AP promoter, and a luciferase gene. Alleles altering expression were further assessed for binding of nuclear proteins by electrophoretic mobility shift assay.

resultsThree SNPs produced PPLDs >40%. One of them, rs12742393, demonstrated significant allelic expression differences in both cell lines tested. The allelic variation at this SNP altered the affinity of nuclear protein binding to this region of DNA.

conclusionsThe A allele of rs12742393 appears to be a risk allele associated with schizophrenia that acts by enhancing transcription factor binding and increasing gene expression.

Indexed as

AllelesBipolar DisorderCanadaCell LineGene ExpressionGenes, ReporterGenetic MarkersGenetic Predisposition to DiseaseGenotypeHumansLinkage DisequilibriumNitric Oxide Synthase Type IPolymorphism, Single NucleotidePrefrontal CortexPsychotic DisordersSchizophreniaGenetic MarkersNitric Oxide Synthase Type I

Identifiers

PMID19255043
PMCPMC3295829
OpenAlexW2119451549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.